Evidence map›Paper›PMID 40918584›Full record

ArticleFrontiers in artificial intelligence2025

Enhancing one-year mortality prediction in STEMI patients post-PCI: an interpretable machine learning model with risk stratification.

Wenqiang Li, Dongdong Yan, Wei Hu, Xiaoling Su, Zheng Zhang

Abstract read
In one paragraph

Article in Frontiers in artificial intelligence, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Wenqiang LiThe First Clinical Medical School, Lanzhou University, Lanzhou, China.
Dongdong YanThe First Clinical Medical School, Lanzhou University, Lanzhou, China.
Wei HuThe First Clinical Medical School, Lanzhou University, Lanzhou, China.
Xiaoling SuDepartment of Cardiology, Qinghai Provincial People's Hospital, Xining, China.
Zheng ZhangThe First Clinical Medical School, Lanzhou University, Lanzhou, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: ST-elevation myocardial infarction (STEMI) poses a significant threat to global mortality and disability. Advances in percutaneous coronary intervention (PCI) have reduced in-hospital mortality, highlighting the importance of post-discharge management. Machine learning (ML) models have shown promise in predicting adverse clinical outcomes. However, a systematic approach that combines high predictive accuracy with model simplicity is still lacking. Methods: This retrospective study applied three data processing and ML algorithms to address class imbalance and support model development. ML models were trained to predict one-year mortality in STEMI patients post-PCI, with performance evaluated using accuracy, sensitivity, precision, F1-score, area under the receiver operating characteristic curve (AUROC), and the area under the precision-recall curve (AUPRC). Results: We analyzed data from 1,274 patients, incorporating 46 clinical and laboratory features. Using the Random Forest (RF) algorithm, we achieved an AUROC of 0.94 (95% confidence interval (CI): 0.90-0.98), an AUPRC of 0.44 (95% CI:0.15-0.76) in the internal validation set, identifying five key predictors: cardiogenic shock, creatinine, NT-proBNP, diastolic blood pressure, and left ventricular ejection fraction. By integrating risk stratification, the model's performance improved, achieving an AUROC of 0.97 (95% CI: 0.96-0.99) and an AUPRC of 0.74 (95% CI: 0.60-0.84). Conclusion: This study highlights the feasibility of constructing accurate and interpretable ML models using a minimal set of predictors, supplemented by risk stratification, to improve long-term outcome prediction in STEMI patients.

Indexed as

data imbalancedata process methodmachine learningone-year mortalityprediction modelST-segment elevation myocardial infarction

Identifiers

PMID40918584
PMCPMC12411920

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.